Emmanuel is the Senior Consultant Strategic Consulting. He leads our global services in Pricing and Payer Research and in Evaluation of Investment Strategies.
Emmanuel focuses primarily on the integrated evaluation of new and established therapeutic solutions to support portfolio investment or in-licensing decisions, and to improve product strategy and operations. From his experience as a strategy consultant with BCG and as head of the R&D Strategy group of Sanofi, he has developed a deep expertise in the strategic analysis of therapeutic interventions and clinical programs. With LASER ANALYTICA, he has built a comprehensive evaluation offer that combines the scientific, medical, commercial, and financial dimensions, with unique insight around payers’ expectations and patient stratification in the real world. Emmanuel has conducted numerous independent assessments of therapeutic programs across a wide array of disease areas and has a broad knowledge of commercialization, market access, and pricing issues in multiple countries. This experience has always been instrumental in delivering insightful recommendations in an expedited way to his clients in biotech, investment funds, or global biopharma companies.
Prior to joining LASER ANALYTICA, Emmanuel headed the R&D Strategy group of Sanofi for 3 years, where he led the annual reviews of all Sanofi and Genzyme development programs presented to the Executive Committee and informed Go/No Go decisions. Previously, he was a Principal with the Boston Consulting Group (Paris and New Jersey) for 7 years, where he advised senior leaders at various biopharma and biotech companies on their strategy, operation, and organization issues, both in the R&D and commercial spaces. He started his career as a scientific project leader with Genethon, a rare disease research institute in the Paris area.
Emmanuel received his PhD in Virology from University Paris VII and is a graduate from Ecole Polytechnique, France.